1 citations
,
December 2021 in “Dermatologic Therapy” Combination therapies are more effective for treating androgenetic alopecia than single treatments.
March 2026 in “Journal of Cosmetic Dermatology” Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.
October 2025 in “Gene Expression” Exosome therapy could be a promising new way to treat hair loss.
January 2023 in “Journal of surgery and research” New treatment effectively reverses hair thinning in most patients with mild side effects.
April 2016 in “Journal of The American Academy of Dermatology” Dutasteride is more effective than finasteride for hair growth with similar side effects.
February 2026 in “Journal of Drugs in Dermatology” Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.
January 2026 in “European Journal of Dermatology” Focus on preserving hair follicle health to prevent hair loss and maintain hair quality.
December 2025 in “The Journal of Clinical Psychiatry” Finasteride can cause depression and suicidal thoughts; safer alternatives are recommended.
August 2024 in “Journal of Cosmetic Dermatology” Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.
New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.
June 2026 in “BMC Biotechnology” The study introduces a novel in vitro organ model for androgenetic alopecia (AGA) that effectively replicates the clinical features and androgen sensitivity of AGA. By optimizing dihydrotestosterone (DHT) concentration and using organotypic culture, the model demonstrated inhibited hair follicle growth, increased apoptosis, and key molecular changes such as decreased β-catenin and IGF-1 expression. It also showed alterations in the Wnt/β-catenin and TGF-β signaling pathways. The model's ability to partially reverse DHT effects with minoxidil or bicalutamide highlights its potential for drug evaluation and personalized therapy development, offering a promising platform for regenerative treatments for AGA.
January 2021 in “Brazilian Journal of Development” Female hair loss causes emotional distress and needs holistic treatment.
January 2010 in “Chinese Journal of Aesthetic Medicine” More severe hair loss and longer treatment improve results.
163 citations
,
November 2003 in “Journal of Investigative Dermatology” Low iron levels may be linked to some types of hair loss in women.
47 citations
,
December 2000 in “Archives of Dermatological Research” Androgens significantly affect female hair loss, and hormonal treatments may help.
46 citations
,
September 2002 in “Journal of the European Academy of Dermatology and Venereology” Women with hair loss often feel depressed, while men are more anxious and aggressive.
34 citations
,
February 2012 in “Journal of Cutaneous Pathology” The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.
16 citations
,
February 2010 in “Journal of the European Academy of Dermatology and Venereology” Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.
4 citations
,
July 2019 in “Vestnik Rossiĭskoĭ akademii meditsinskikh nauk / Rossiĭskaia akademiia meditsinskikh nauk” Both genetics and lifestyle factors contribute to male pattern baldness.
3 citations
,
November 2020 in “Journal of The American Academy of Dermatology” The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.
3 citations
,
April 2002 in “The Lancet” Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.
3 citations
,
July 2001 in “PubMed” Finasteride helps manage male hair loss, but realistic expectations and support are crucial.
2 citations
,
April 2021 in “Journal of Cosmetic Dermatology” Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.
June 2026 in “Russian Journal of Skin and Venereal Diseases” A study involving 20 patients with androgenetic alopecia evaluated the efficacy of salmon-derived exosomes combined with microneedling. Over 12 weeks, significant improvements were observed: hair density increased by 44.4 hairs/cm², the proportion of vellus hairs decreased, hair shaft diameter increased by 22.4 µm, and the proportion of anagen hairs rose by 36.4%. Histological analysis showed increased follicular density and normalization of the terminal/vellus ratio, while immunohistochemistry indicated enhanced cellular proliferation and angiogenesis. No serious adverse events were reported. The treatment effectively restored hair follicle function and reversed miniaturization, suggesting salmon-derived exosomes as a promising regenerative strategy for androgenetic alopecia.
January 2026 in “Medico Research Chronicles” Homeopathy improved hair loss and well-being in a woman with chronic hair loss.
November 2025 in “Skin Appendage Disorders” Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.
November 2025 in “Open Repository of the University of Porto (University of Porto)” Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.
Continuous treatment is essential to manage male pattern baldness effectively.
April 2024 in “Tạp chí Y học Thảm hoạ và Bỏng” Choosing the right treatment for hair loss is complex and depends on effectiveness, side effects, practicality, and cost.
January 2024 in “Brazilian Journal of Hair Health” Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.